In a strategic move to expand its footprint in the paediatric and wellness segment, Cipla Limited has announced the acquisition of Inzpera Healthsciences Ltd for ₹110.65 crore.The acquisition underscores Cipla’s continued focus on diversified consumer healthcare solutions, particularly in the areas of child nutrition, gut
Mankind Pharma, India’s fourth largest pharmaceutical company, today announced a collaboration with OpenAI, a leading AI research and deployment company, to institutionalize AI across its value chain. As one of the first few Indian pharma companies to fully integrate advanced AI into core operations, Mankind
Emcure Pharmaceuticals Ltd., a leading Indian pharma company with a strong focus on women’s health, announces its entry into the daily supplements space with the expansion of its Arth range. With a comprehensive approach to holistic well-being, Arth offers a wide range of supplements that
The Indian pharmaceutical sector is strategically poised to capitalize on the recent healthcare initiatives introduced by President Donald Trump, aimed at enhancing the affordability and accessibility of medical treatments in the United States. This development presents significant opportunities for Indian drug manufacturers to expand their
Indian pharma companies are incorporating AI algorithms into their R&D operations, clinical trials and streamlining processes Firms deploying GenAI are seeing reduction in early-stage drug development costs, and improvement in operational efficiencies EY Parthenon (EY-P), the leading strategy consulting firm, in partnership with BioAsia,
With an aim to create awareness and build the capabilities of the Indian pharma sector to adopt global best manufacturing practices, the Indian Pharmaceutical Alliance (IPA) is organizing the 7th Advanced Good Manufacturing Practices Workshop. The workshops will be conducted across three locations – Ahmedabad
